吴承根之前和丘栋荣一起合管过中庚价值灵动灵活配置。 来源：硬核姬老板 好久没盘基金经理动向了，最近有一些动态值得说一下。 一、中庚基金的吴承根也跳槽去广发了 前阵子有人在后台给我留言问我吴承根去哪了。 他不提醒我都不知道吴承根已经离职了，周末看见动向，原来他也跳槽去广发了…… 这只基金他们内部定位是非常清晰的，他们不做工具类产品，就是低估值价值策略下的低波动、具备资 产配置功能的产品。 后面丘离任后，吴承根开始独挑大梁，截至离职，中庚价值灵动灵活配置5年收益166%，同时回撤控制 的也不错。 也算是丘之后，中庚另外一个被认可的基金经理了。 其实丘那时候要走，他们所有基金经理全部出来路演了一下，当初我也在会议里面听了一下，说实话， 如果他们能前置这个事情就好了。 其他基金经理说的也非常好，大家都各有特点。 其中吴承根的特点是低估值的价值投资策略。 他是以绝对收益为导向，严格控制回撤，核心在于从中微观层面寻找低估值、高预期回报的结构性机 会，尤其关注供给侧有约束、需求有空间或平衡的行业。 并反对简单追逐高分红策略（主要是因为单因子策略风险较高，除非与其他因子比如说周期成长、资本 供给、创新等叠加以降低风险），整体 ...

Core Insights - The performance of equity funds has significantly improved in 2023, with 96.58% of 7982 equity funds achieving net value growth, compared to only 18.63% in the same period last year [1] - A total of 46 equity funds have seen their net value double, with notable contributions from various fund management companies focusing on technology and healthcare sectors [1][2] Group 1: Fund Performance - As of September 23, 2023, 7709 out of 7982 equity funds have reported net value growth, marking a substantial increase in performance compared to the previous year [1] - The number of "doubling funds" with over 100% net value growth has reached 46, indicating strong market interest and investment returns [1] Group 2: Sector Focus - Several funds have achieved remarkable results by investing in the technology sector, particularly in AI and cloud computing, with the top-performing fund showing a 201.63% net value growth [1] - Funds such as Huatai-PB Quality Selected Mixed and Xinao Performance Driven Mixed are also focusing on AI, while others like Bank of China Hong Kong Stock Connect Medical Mixed are targeting innovative pharmaceuticals [2] Group 3: Industry Trends - The rapid development of technologies such as AI, biomedicine, and blockchain is reshaping the integration of technology, industry, and finance, as highlighted by the China Securities Regulatory Commission [2] - Fund managers express confidence in the ongoing transformation driven by AI and the potential for growth in China's manufacturing and new consumption sectors due to structural changes in the economy and population [2] Group 4: Innovation in Pharmaceuticals - The innovation drug sector is expected to perform well due to a combination of fundamental breakthroughs, policy support, and valuation recovery, according to industry experts [3] - Domestic innovative drug companies are seen to have advantages in clinical research speed and R&D costs, which are expected to drive rapid development in the sector [3]

Core Insights - The global technology wave is accelerating, with surging demand for AI computing power, rapid chip localization, and increasing penetration of new energy reshaping the economic landscape [1] - Cinda Australia Fund focuses on diverse technology sectors, building an investment matrix to provide asset allocation solutions that align with current opportunities [1][2] - The fund emphasizes a robust research and investment system, leveraging experienced fund managers and integrating financial technology for data analysis and industry research [1][2] Investment Performance - As of June 30, 2025, several funds have significantly outperformed their benchmarks, with the Cinda Australia New Energy Selected Mixed Fund A showing a net value growth rate of 67.93% compared to a benchmark return of 25.86% [2] - The Cinda Australia Advanced Intelligent Manufacturing Fund A achieved a net value growth rate of 60.39%, against a benchmark return of 15.88% [2] - The Cinda Australia Prosperity Selected Mixed Fund A recorded a net value growth rate of 46.75%, while its benchmark return was 14.72% [2] Fund Structure and Strategy - Cinda Australia has developed a diverse product matrix covering the entire technology industry chain, catering to various risk preferences [1][2] - The product offerings include equity and mixed funds, focusing on growth and value styles, with specific sectors such as computing infrastructure, new energy, intelligent manufacturing, and AI applications [1] - The fund's investment approach combines quantitative and active management, allowing for precise identification of investment opportunities through real-time data analysis [1][2] Fund Manager Profiles - Fund manager Li Bo holds a master's degree in electrical engineering and has extensive experience in the investment field, currently managing the Cinda Australia New Energy Selected Mixed Fund [4] - Fund manager Qi Xingfang, with a background in business administration, has been with Cinda Australia since 2021 and manages the Cinda Australia Advanced Intelligent Manufacturing Fund [5] - Fund manager Wu Qingyu, with degrees in economics and finance, has a strong background in industry research and currently manages the Cinda Australia Prosperity Selected Mixed Fund [7]